Answers are grounded in this paper and cite their sources.
This study investigated the DPP-4 inhibitory and insulin signaling modulating activities of Allomyrina dichotoma (rhinoceros beetle) larval protein hydrolysate. Following enzymatic hydrolysis, three fractions were obtained by HPLC fractionation. Among them, fraction 3 (F3) exhibited the strongest dipeptidyl peptidase-4 (DPP-4) inhibitory activity (IC 50 : 0.72 mg/mL). In an insulin-resistant HepG2 cell model, F3 significantly increased glucose uptake and enhanced Akt phosphorylation at Thr308, along with upregulation of GLUT4 expression, indicating improved insulin signaling responses. Furthermore, LC–MS/MS analysis identified 22 compounds enriched in hydrophobic and aromatic amino acids within F3. Molecular docking analysis predicted that these compounds interact with key DPP-4 active-site residues, including Glu205/Glu206, Tyr547, and Tyr662. Additionally, quantitative analysis revealed substantial levels of Trp, Val-Leu, and Met-Leu, which have previously been reported as DPP-4 inhibitory compounds. Collectively, these findings suggest that A. dichotoma larval hydrolysate contains bioactive peptides with DPP-4-inhibitory and insulin-signaling-modulating properties, supporting its potential for glucose homeostasis.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: